Sustained Clinical Benefit After 3 Year Follow Up in Scleroderma Trial
/
Date05 Dec 2016
SAN DIEGO, Dec. 05, 2016 (GLOBE NEWSWIRE) — Cytori Therapeutics, Inc. (NASDAQ:CYTX) Topline review of early three-year follow-up data from the SCLERADEC I trial shows sustained... Read More →
Biothera Pharmaceuticals and Merck Further Expand Research Collaboration to Include Phase 2 Clinical Trial in Head and Neck Cancer
/
Date05 Dec 2016
EAGAN, Minn., Dec. 05, 2016 (GLOBE NEWSWIRE) — Biothera Pharmaceuticals, Inc. today announced an expansion of its research collaboration with Merck (known as MSD outside... Read More →
Help Create 1 Million More Swimmers Through Step Into Swim
/
Date05 Dec 2016
COLORADO SPRINGS, Colo., Dec. 5, 2016 (GLOBE NEWSWIRE) — The National Swimming Pool Foundation® (NSPF®) continues its 2012 mission to create 1 million more swimmers... Read More →
Novo Nordisk indsender registreringsansøgning i USA og EU for semaglutid til dosering én gang ugentligt til behandling af type 2-diabetes
/
Date05 Dec 2016
Bagsværd, den 5. december 2016 – Novo Nordisk meddeler i dag, at virksomheden har indsendt registreringsansøgninger til de amerikanske sundhedsmyndigheder (FDA) og Det Europæiske Lægemiddelagentur... Read More →
Novo Nordisk files for regulatory approval of once-weekly semaglutide in the US and EU for the treatment of type 2 diabetes
/
Date05 Dec 2016
Bagsværd, Denmark, 5 December 2016 – Novo Nordisk today announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration... Read More →
Minerva Neurosciences’ Clinical Data Featured at The American College of Neuropsychopharmacology Annual Meeting
/
Date05 Dec 2016
Oral presentation highlights specific improvements in negative symptoms and cognition observed in schizophrenic patients treated with MIN-101 in Phase IIB trial Data also presented from... Read More →
Celldex Presents Data on CDX-1140, a Novel CD40 Agonist Antibody for Hematologic and Solid Malignancies, at the American Society of Hematology (ASH) Annual Meeting
/
Date05 Dec 2016
HAMPTON, N.J., Dec. 05, 2016 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) presented data on new product candidate CDX-1140, a fully human antibody targeted to... Read More →
Cancer Genetics, Inc. Listed by Merck as a National Reference Laboratory for KEYTRUDA® (pembrolizumab) Companion Diagnostic Testing
/
Date05 Dec 2016
Reinforces CGI’s Position as a Leader in Immuno-Oncology & Companion Diagnostics For PD-L1 Testing & Monitoring Company Expects Significant Growth in Comprehensive Molecular & Immune... Read More →
Onconova Presents Phase 2 Data from Oral Rigosertib and Azacitidine Combination Trial in Higher-Risk Myelodysplastic Syndromes (HR-MDS) at 2016 ASH Annual Meeting
/
Date05 Dec 2016
–35% Complete Remission (CR) Rate for Combination in 1st-line Higher-risk MDS Patients– –Updated Median Duration of Complete Response of 8 Months in All Responding Patients—... Read More →
Z-Medica Teams Up with the American College of Surgeons Providing Basic Bleeding Control Instructor Training
/
Date05 Dec 2016
WALLINGFORD, Conn., Dec. 5, 2016 (GLOBE NEWSWIRE) — via PRWEB – Z-Medica, LLC, a leading developer and marketer of hemostatic devices, announces today that they... Read More →